Fujian Pacific Pharmaceutical Co.,Ltd. was established in 1992 and located in Quanzhou Economic and Technological Development Zone, Fujian Province, with a plant area of 60,000 square meters and a construction area of nearly 100,000 square meters. It is a pharmacy company that produces chemical preparations and proprietary Chinese medicines. It currently has 61 products with code number approved by SFDA, and has built 5 GMP-certified production workshops to produce tablets, hard capsules, creams（including hormones）, liniment, medicinal tea, gels, large-volume injection(three-layer co-extruded infusion bags), and oral solution preparations (in the construction). The products are sold to all provinces and cities in China and become long-term quality cooperatives with China Pharmaceutical Top 100 Pharmaceutical Enterprises, such as Renhe, Xiuzheng and Sunflower.
The company's main products are Ibuprofen Sustained-release Capsules, Triamcinolone Acetonide and Econazole Cream, wind medicated oil, Compositus Mentholi Cream and other products. These products are ranked among the top five in China. The company holds the Luoshangshan Pharmaceutical Factory in Quanzhou, Fujian Province (the manufacturer with large scale of production and sales of Chinese granules in Fujian, with 36 product approvals), and merged and acquired Baitongtang （Fujian） Biological Pharmaceutical Co., Ltd.（formerly Anxi Pharmaceutical Factory）. It is a leading enterprise in Quanzhou's pharmaceutical industry.
The company（including Luoshangshan Pharmaceutical Factory） has annual sales of over RMB 200 million. It has established sales offices in various provinces across China, with more than 40 sales teams and cooperation with thousands of pharmaceutical companies. It is a pharmaceutical industry enterprise with a large production and sales volume in Quanzhou. The company has strong technical strength and has a high-quality workforce. Professional and technical personnel account for 40% of the total number of employees. It has established a high-level R&D and testing center, and has independently undertaken pharmaceutical research for chemical consistency evaluation and obtained a high-tech enterprise certificate. The company has established a doctoral expert workstation with a national talent team and maintain a long-term strategic partnership with well-known research and development companies in Shanghai and Beijing. It actively invests in high-end drug research and development, aiming at providing quality products and services to patients, and promoting the development of “Tai Ping” brand with technology and quality.
Fujian Pacific Pharma, which has the courage to develop and innovate, has strong talents, technology and capital advantages. It has a strong development momentum and always adheres to the tenet of “survive by quality, develop by credit” and “seeking win-win”, seeking mutual trust partners to make great achievements together!